FDA inspection
Ingenus Pharmaceuticals NJ, LLC.: FDA inspection ending Jul 17, 2026
FDA inspection 1326668 · Voluntary Action Indicated (VAI) · Fairfield, NJ
Key facts
| Inspection ID | 1326668 |
|---|---|
| Firm | Ingenus Pharmaceuticals NJ, LLC. |
| FEI number | 2246963 |
| City | Fairfield |
| State | NJ |
| ZIP | 07004 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Jul 17, 2026 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data